Dr. Lantz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 Martha Jefferson Dr
Charlottesville, VA 22911Phone+1 434-654-7580Fax+1 434-654-7582
Summary
- Dr. Jeffrey Lantz, DO, is an oncology specialist based in Charlottesville, VA. He completed his chief residency and residency in Internal Medicine at Wake Forest University Baptist Medical Center from 2018 to 2022, and he is currently pursuing a fellowship in Hematology and Medical Oncology at the University of Virginia Medical Center (2022-2025). He graduated from the Edward Via Virginia College of Osteopathic Medicine in 2018. Dr. Lantz has authored publications in areas including hematologic malignancies and immunotherapy-related conditions, with articles featured in journals such as Current Hematologic Malignancy Reports and Blood Reviews.
Education & Training
- University of Virginia Medical CenterFellowship, Hematology and Medical Oncology, 2022 - 2025
- Wake Forest University Baptist Medical CenterChief Residency, Internal Medicine, 2021 - 2022
- Wake Forest University Baptist Medical CenterResidency, Internal Medicine, 2018 - 2021
- Edward Via Virginia College of Osteopathic MedicineClass of 2018
Certifications & Licensure
- VA State License 2022 - 2026
- NC State License 2018 - 2023
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 1 citationsBlinatumomab in Practice.Jeffrey Lantz, Natalie Pham, Caroline Jones, Daniel Reed, Firas El Chaer
Current Hematologic Malignancy Reports. 2024-02-01 - 4 citationsCentral nervous system prophylaxis in diffuse large B-cell lymphoma: What does the evidence tell us?Jeffrey Lantz, Craig A Portell, Emily C Ayers
Blood Reviews. 2023-09-01 - A Novel Workflow to Create a Checkpoint Inhibitor Pneumonitis Patient Registry.Andrew Faucheux, Eric Olson, Jeffrey Lantz, Nathan Roberts, Vanya Aggarwal
Cureus. 2023-02-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: